taken together , the data presented suggest that lsi is a specific inhibitor of the response of sensitized lymphocytes to ebv antigens and that it may indeed represent a marker of great clinical significance regarding undifferentiated nasopharyngeal carcinoma , particularly for its prognosis .
C0024262
lsi
C0003320
antigens